Former USPTO directors challenge Vidal’s patent outreach

Hazards of Counterfeit Products, Record Low – or Is It?

The IP News that Mattered Most in 2022, According to You

WTO divided over expanding COVID-19 IP waiver

C4IP Presents Webinar on COVID Waiver Extension

Two former Commerce Department executives take on intellectual property protection

Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver

Former Commerce, USPTO Heads Push for U.S. to Lead Opposition to Extending WTO’s COVID IP Waiver

Is China set to pass the US as the world’s lead innovators?

How China steals U.S. intellectual property

Iancu-Backed Group Urges Lawmakers To Support Tillis IP Bill

Letters Seek to Dispel Gene Patent ‘Scaremongering’ Surrounding Tillis’ Patent Eligibility Bill

“Any suggestion that this legislation would allow companies to patent anyone’s DNA is simply false,” C4IP writes, adding that the ‘scaremongering’…ignores the ...
Scroll to Top